Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Relapsing Remitting Hispanic Multiple Sclerosis Forms

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2012 by University of Southern California
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Lilyana Amezcua, University of Southern California
ClinicalTrials.gov Identifier:
NCT01592097
First received: May 1, 2012
Last updated: June 29, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)